A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease.
A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease.
复制标题
SARS-CoV-2 主要蛋白酶的可逆共价二肽基抑制剂的系统调查。
DOI:
10.1021/acs.jmedchem.3c00221
复制
发表时间:
2023
影响因子:
7.3
通讯作者:
Allen,Robe
中科院分区:
文献类型:
--
作者:
Geng,ZhiZachary;Atla,Sandeep;Shaabani,Namir;Vulupala,Veerabhadra;Yang,KaiS;Alugubelli,YugendarR;Khatua,Kaustav;Chen,Peng-Hsun;Xiao,Jing;Blankenship,LaurenR;Ma,XinyuR;Vatansever,ErolC;Cho,Chia-ChuanD;Ma,Yuying;Allen,Robe
SARS-CoV-2, the COVID-19 pathogen, relies on its main protease (MPro) for replication and pathogenesis. MProis a demonstrated target for the development of antivirals for SARS-CoV-2. Past studies have systematically explored tripeptidyl inhibitors such as nirmatrelvir as MProinhibitors. However, dipeptidyl inhibitors especially those with a spiro residue at their P2 position have not been systematically investigated. In this work, we synthesized about 30 dipeptidyl MProinhibitors and characterized them on enzymatic inhibition potency, structures of their complexes with MPro, cellular MProinhibition potency, antiviral potency, cytotoxicity, andin vitrometabolic stability. Our results indicated that MProhas a flexible S2 pocket to accommodate inhibitors with a large P2 residue and revealed that dipeptidyl inhibitors with a large P2 spiro residue such as (S)-2-azaspiro [4,4]nonane-3-carboxylate and (S)-2-azaspiro[4,5]decane-3-carboxylate have favorable characteristics. One compound, MPI60, containing a P2 (S)-2-azaspiro[4,4]nonane-3-carboxylate displayed high antiviral potency, low cellular cytotoxicity, and highin vitrometabolic stability.